Evidence map›Paper›PMID 40599166›Full record

ArticleBrain communications2025

Loss of the NF-κB negative regulator Pirk in

Srishti Arora, Grace Critchley, Amira San Dekmak, Gero Miesenböck, Anissa Kempf, Petros Ligoxygakis

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Srishti AroraDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Grace CritchleyDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Amira San DekmakDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Gero MiesenböckCentre for Neural Circuits and Behaviour, University of Oxford, OX1 3SR, UK.
Anissa KempfCentre for Neural Circuits and Behaviour, University of Oxford, OX1 3SR, UK.
Petros LigoxygakisDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A gut-brain axis influenced by host innate immunity and resident microbiota has been implicated in neurological conditions including Alzheimer's disease. However, the precise connection of innate immunity to Alzheimer's disease remains unclear. Using Pirk, a negative regulator of the IMD/NF-κB pathway in

Indexed as

DrosophilaimmunityinflammationneurodegenerationNF-κB

Identifiers

PMID40599166
PMCPMC12209854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.